GlassScriptPhysician profile
Abid Hussain
NPI 1821157462
$10,319.39
in general payments reported to CMS, 2019-2025
61 companies · $1,390 in 2025
The $1,390 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,361 · 2020: $1,325 · 2021: $1,995 · 2022: $1,561 · 2023: $1,342 · 2024: $1,345 · 2025: $1,390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,077.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,077.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,187.13 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $1,099.43 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $870.05 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $699.75 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $619.77 | 2019-2024 | Spiriva Respimat, Jardiance, Stiolto Respimat |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $510.96 | 2019-2025 | Xifaxan |
| Abbott Laboratories | $359.32 | 2022-2025 | Freestyle Libre 3 |
| Pfizer INC. | $354.23 | 2019-2024 | |
| Lilly USA, LLC | $308.98 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Merck Sharp & Dohme LLC | $289.40 | 2019-2022 | |
| Koya Medical, INC. | $281.34 | 2024 | Dayspring, Koya Medical |
| Amgen INC. | $241.86 | 2020-2025 | Repatha, Otezla, Otezla |
| Glaxosmithkline, LLC. | $237.77 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Corcept Therapeutics | $208.30 | 2022-2025 | Korlym |
| Allergan, INC. | $192.77 | 2019-2020 |
Show all 61 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abid Hussain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.